Immune tolerance induction with human-cl rhFVIII in patients with severe haemophilia A and inhibitors

被引：0
|
作者：
Hall, G. [1 ]
Bhatnagar, N. [1 ]
Khair, K. [2 ]
Wilkinson, A. [1 ]
Belyanskaya, L. [3 ]
Liesner, R. [2 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Childrens Hosp Oxford, Oxford Haemophilia & Thrombosis Comprehens Care C, Oxford, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, Haemophilia Comprehens Care Ctr, London, England
[3] Octapharma AG, Lachen, Switzerland
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P115
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Clinical study in children with severe haemophilia A investigating efficacy, immunogenicity, pharmacokinetics, and safety of human-cl rhFVIII
    Klukowska, A.
    Vdovin, V.
    Szczepanski, T.
    Jansen, M.
    Knaub, S.
    Liesner, R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 532 - 532
  • [22] Long-term tolerability, immunogenicity and efficacy of Nuwiq® (human-cl rhFVIII) in children with severe haemophilia A
    Klukowska, A.
    Szczepanski, T.
    Vdovin, V.
    Knaub, S.
    Bichler, J.
    Jansen, M.
    Dzhunova, I.
    Liesner, R. J.
    [J]. HAEMOPHILIA, 2018, 24 (04) : 595 - 603
  • [23] Clinical study in children with severe haemophilia a investigating efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIII
    Walter, O.
    Liesner, R.
    Jansen, M.
    Knaub, S.
    [J]. HAEMOPHILIA, 2013, 19 : 75 - 76
  • [24] Clinical study in children with severe haemophilia A investigating efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIII
    Liesner, R.
    Klukowska, A.
    Vdovin, V.
    Szczepanski, T.
    Jensen, M.
    Knaub, S.
    [J]. HAEMOPHILIA, 2013, 19 (03) : 468 - 468
  • [25] Inhibitor Development in Previously Untreated Patients with Severe Haemophilia a Treated with Human-CL RHFVIII, a New Generation Recombinant FVIII of Human Origin
    Neufeld, E. J.
    Abashidze, M.
    Aleinikova, O.
    Altisent, C.
    Belletrutti, M. J.
    Borel-Derlon, A.
    Carcao, M.
    Chambost, H.
    Chan, A. K. C.
    Dubey, L.
    Ducore, J.
    Fouzia, N. A.
    Gattens, M.
    Gruel, Y.
    Kavardakova, N.
    El Khorassani, M.
    Klukowska, A.
    Koenigs, C.
    Lambert, T.
    Liesner, R. J.
    Lohade, S.
    Sigaud, M.
    Turea, V.
    Wu, J. K.
    Vdovin, V.
    [J]. HAEMOPHILIA, 2017, 23 : 24 - +
  • [26] Long-term immunogenicity, safety and efficacy of human-cl rhFVIII in previously treated children with severe haemophilia A
    Klukowska, Anna
    Vdovin, Vladimir
    Szczepanski, Tomasz
    Irena, Dzhunova
    Liesner, Raina
    Bichler, Johann
    [J]. HAEMOPHILIA, 2016, 22 : 52 - 52
  • [27] Long-Term Immunogenicity, Safety and Efficacy of Human-cl rhFVIII in Previously Treated Children with Severe Haemophilia A
    Klukowska, A.
    Vdovin, V.
    Szczepanski, T.
    Bichler, J.
    Dzhunova, I.
    Liesner, R.
    [J]. HAEMOPHILIA, 2016, 22 : 96 - 96
  • [28] Bioequivalence of Human-Cl Rhfviii and Kogenate Fs in Previously Treated Patients with Severe Hemophilia A
    Knaub, Sigurd
    Manco-Johnson, Marilyn
    Lissitchkov, Toshko
    Tiede, Andreas
    Powell, Jerry
    Valentino, Leonard
    Bichler, Johann
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S165 - S165
  • [29] Inhibitor Development and Efficacy in Previously Untreated Patients with Severe Haemophilia A Treated with Human-cl rhFVIII*, a New Generation Recombinant FVIII of Human Origin
    Liesner, R.
    Jansen, M.
    Belyanskaya, L.
    Neufeld, E.
    [J]. HAEMOPHILIA, 2017, 23 : 25 - 26
  • [30] Immune Tolerance Induction in paediatric patients with severe Haemophilia A with inhibitors: Malaysian experience
    Salim, Nik Nabilah Nik Mohd
    [J]. HAEMOPHILIA, 2020, 26 : 33 - 33
12345